Existing Research
Despite growing interest in DAND, our understanding of these syndromes remains limited. To date, only about 30 research publications — produced by a dozen research groups and centers — have focused exclusively on the DEAF1 gene. Since many fundamental scientific questions are best explored through simplified models of disease, DAND pathology has been studied using in vitro systems, human cellular models (including HEK293 cells and patient-derived organoids), and mouse models.
Cutting-edge research methods, such as recombinant DNA technology, transcriptomic analysis, and computational modeling are helping scientists close key knowledge gaps. These approaches allow researchers to better understand DEAF1’s genetic and cellular functions, the biologic pathways it influences, and the effects of DEAF1 mutations. On the clinical side, studies have primarily focused on cataloging symptoms through diagnostic imaging, behavioral assessments, clinical notes, and systems evaluations—typically with little or no direct intervention.
Researcher? The DAND Alliance has created a Scientific Q&A to help answer more specific questions regarding the DEAF1 gene mechanistic biology. Please contact us for more information.
The Role of DEAF1 in Denritic and Synaptic Development: Insights Into Neurodevelopmental Disorders
Conditional knockout of DEAF1 gene in a mouse model impairs memory and evokes anxiety-like behavior, associated with abnormal morphology of hippocampus.
Expansion and mechanistic insights into de novo DEAF1 variants in DEAF1-associated neurodevelopmental disorders
De novo DEAF1 variants in the DNA binding domain result in a spectrum of neurodevelopmental disorders through dominant-negative effects on DEAF1’s regulation of other genes.